Randomized Phase II Trial of Letrozole and Letrozole Plus Low-Dose Metronomic Oral Cyclophosphamide As Primary Systemic Treatment in Elderly Breast Cancer PatientsAlberto Bottini, Alfredo Berruti, Alessandra Bersiga et al.|Journal of Clinical Oncology|2006Cited by 190
Down-Regulation of Phosphatidylinositol 3′-Kinase/AKT/Molecular Target of Rapamycin Metabolic Pathway by Primary Letrozole-Based Therapy in Human Breast CancerDaniele Generali, Alfredo Berruti, Stephen B. Fox et al.|Clinical Cancer Research|2008Cited by 55